nayana-c1.867c992ae9100904cc61c84591adf0f8f863e0387e30f0d0dbc86640e9f50a1a.zh.train.131027
nayana-c1.867c992ae9100904cc61c84591adf0f8f863e0387e30f0d0dbc86640e9f50a1a.zh.train.131027: train task in FineEnvs/nayana-ocr-env, an RL environment on the Hugging Face Hub. 用Lenvima和Pembrolizumab治疗的患者中有多少百分比会出现致命的不良反应？ A. 2.5％ B. 4.7％ C. 6.1％ D. 7.8％ Return only the single uppercase letter of the…
The task
用Lenvima和Pembrolizumab治疗的患者中有多少百分比会出现致命的不良反应？ A. 2.5％ B. 4.7％ C. 6.1％ D. 7.8％ Return only the single uppercase letter of the correct option.
Task details
- language
- zh
- family
- mcq_vqa
- mime
- image/jpeg
- media ready
- False